AEGON ASSET MANAGEMENT UK Plc
Source: SEC Form 13F · as of Mar 2026AEGON ASSET MANAGEMENT UK Plc holds 13 biotech & pharma companies tracked by BioSniper, totaling $620.0M in value as of Mar 2026 (SEC Form 13F).
Companies held
13
Total value held
$620.0M
| Company | Shares | Value |
|---|---|---|
| MRKMerck & Co., Inc. | 1,274,506 | $153.1M |
| JNJJOHNSON & JOHNSON | 524,731 | $128.2M |
| ABBVAbbVie Inc. | 498,848 | $108.1M |
| BMYBRISTOL MYERS SQUIBB CO | 1,198,199 | $72.7M |
| LLYELI LILLY & Co | 63,991 | $58.9M |
| BIIBBIOGEN INC. | 258,735 | $47.4M |
| GILDGILEAD SCIENCES, INC. | 222,946 | $31.1M |
| DGXQuest Diagnostics Incorporated | 90,605 | $17.8M |
| IDXXIDEXX LABORATORIES INC /DE | 2,296 | $1.3M |
| MCKMcKesson Corporation | 1,097 | $949K |
| PMPhilip Morris International Inc | 3,363 | $556K |
| PFEPFIZER INC | 4,280 | $120K |
| VTRSViatris Inc | 531 | $7K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.